Medtronic PLC

MDT Healthcare Medical Devices

Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025.

Revenue
+13.7%
EPS
+42.0%
Free cash flow
+120.9%
Total debt
−1.59%

Quarter to July 2026, against a year earlier

101.77 3.07 −2.93%
Market cap
$134.1B
P/E
25.6×
Fwd P/E
20.8×
Dividend yield
2.74%
F-score
7/9
Altman Z
2.73
Beneish M
−2.58
Dividend safety
61/100
Older periods Oct '25 Jan '26 Apr '26 Jul '26
P/E ratio

+8 more quarters

24.45 28.61 21.65 20.93
P/S ratio
3.35 3.71 2.85 2.91
P/FCF ratio
22.34 24.35 19.13 17.82
P/Operating CF
125.71 48.01 40.34 60.95
P/B ratio
2.38 2.68 2.07 2.15
EV/Sales
3.94 4.27 3.37 3.43
EV/EBITDA
14.85 16.62 13.00 13.23
EV/FCF
26.33 27.99 22.58 20.97
Current Ratio
2.42 2.54 2.13 2.07
Net Debt/EBITDA
8.55 8.90 7.24 7.76
Debt/Equity
0.60 0.57 0.56 0.55
Earnings Yield
4.09% 3.50% 4.62% 4.78%
Free Cash Flow Yield
4.48% 4.11% 5.23% 5.61%
Free Cash Flow per Share
0.36 1.79 1.63 1.01
Book value per Share
38.11 38.36 39.06 39.73
Free Cash Flow
457.00 2,300.00 2,085.00 1,290.00
EV/EBIT
22.06 25.11 18.95 18.95
Other line items

Show all line items

Columns are period end dates